Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan
Open Access
- 28 December 2021
- journal article
- research article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 38 (3) , 417-426
Abstract
Prostate cancer is a common malignancy and patients may progress to castration-resistant prostate cancer (CRPC). Among patients with CRPC, fatigue is a common symptom associated with current treatm...Keywords
This publication has 25 references indexed in Scilit:
- Androgen deprivation therapy: evidence‐based management of side effectsBJU International, 2013
- Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapyAnnals of Oncology, 2011
- Characterising the castration-resistant prostate cancer population: a systematic reviewInternational Journal Of Clinical Practice, 2011
- Environmental triggers of autoimmune thyroiditisJournal of Autoimmunity, 2009
- Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathwaysBJU International, 2009
- Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate CancerNew England Journal of Medicine, 2004
- Validation Study of the Japanese Version of the Brief Fatigue InventoryJournal of Pain and Symptom Management, 2003
- Fatigue in women treated with bone marrow transplantation for breast cancer: A comparison with women with no history of cancerSupportive Care in Cancer, 1997
- Prevalence of symptoms among patients with advanced cancer: An international collaborative studyJournal of Pain and Symptom Management, 1996
- Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancerJournal of Pain and Symptom Management, 1995